Pages that link to "Q59087524"
Jump to navigation
Jump to search
The following pages link to Recombinant erythropoietin in urine (Q59087524):
Displaying 50 items.
- Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones (Q28216817) (← links)
- Molecular synapomorphies resolve evolutionary relationships of extant jawed vertebrates (Q28775729) (← links)
- Analytics of nonpeptidic erythropoietin mimetic agents in sports drug testing employing high-resolution/high-accuracy liquid chromatography-mass spectrometry (Q30390786) (← links)
- Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement (Q30409171) (← links)
- Characterisation of intact recombinant human erythropoietins applied in doping by means of planar gel electrophoretic techniques and matrix-assisted laser desorption/ionisation linear time-of-flight mass spectrometry (Q33211610) (← links)
- Blood cells RNA biomarkers as a first long-term detection strategy for EPO abuse in horseracing. (Q33649999) (← links)
- Lateral transfer at the gene and subgenic levels in the evolution of eukaryotic enolase (Q33943804) (← links)
- Physiology of professional road cycling (Q34248379) (← links)
- Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era. (Q34453363) (← links)
- Erythropoietin prevents PC12 cells from beta-amyloid-induced apoptosis via PI3K⁄Akt pathway (Q34501237) (← links)
- Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid. (Q34511081) (← links)
- Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control (Q34538186) (← links)
- Doping control for the team physician: a review of drug testing procedures in sport (Q34559334) (← links)
- Recombination between elongation factor 1alpha genes from distantly related archaeal lineages (Q34574795) (← links)
- Red blood cells (Q34962353) (← links)
- Pharmacokinetics/Pharmacodynamics of Recombinant Human Erythropoietins in Doping Control1 (Q35104618) (← links)
- Organ specific regenerative markers in peri-organ adipose: kidney (Q35305543) (← links)
- The Tour de France: a physiological review (Q35542395) (← links)
- Serum proteomic changes after randomized prolonged erythropoietin treatment and/or endurance training: detection of novel biomarkers. (Q35560616) (← links)
- Site-specific qualitative and quantitative analysis of the N- and O-glycoforms in recombinant human erythropoietin (Q35577821) (← links)
- The influence of artificially introduced N-glycosylation sites on the in vitro activity of Xenopus laevis erythropoietin (Q35610754) (← links)
- Doping with artificial oxygen carriers: an update (Q35676909) (← links)
- Variability in the immunodetection of His-tagged recombinant proteins (Q35677721) (← links)
- Autologous Doping with Cryopreserved Red Blood Cells - Effects on Physical Performance and Detection by Multivariate Statistics (Q36048055) (← links)
- Caspase activation, sialidase release and changes in sialylation pattern of recombinant human erythropoietin produced by CHO cells in batch and fed-batch cultures (Q36254996) (← links)
- Erythropoiesis-stimulating agents and other methods to enhance oxygen transport (Q36736105) (← links)
- Technology insight: detecting growth hormone abuse in athletes (Q36978818) (← links)
- Illicit organogenesis: Methods and substances of doping and manipulation (Q37080330) (← links)
- Oxygen delivery enhancers: past, present, and future (Q37117367) (← links)
- Anti-doping testing at the 2008 European football championship (Q37721918) (← links)
- Surface plasmon resonance in doping analysis. (Q37859306) (← links)
- Recent developments in doping testing for erythropoietin (Q37884431) (← links)
- Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport (Q37989124) (← links)
- Biomarker monitoring in sports doping control (Q38014969) (← links)
- The sweet tooth of biopharmaceuticals: importance of recombinant protein glycosylation analysis. (Q38029304) (← links)
- Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories (Q38029404) (← links)
- Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future (Q38029405) (← links)
- From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports? (Q38119906) (← links)
- Current strategies of blood doping detection (Q38128215) (← links)
- An integrative 'omics' solution to the detection of recombinant human erythropoietin and blood doping (Q38195814) (← links)
- Detection of peptidic erythropoiesis-stimulating agents in sport (Q38200014) (← links)
- Ultrasensitive bioanalysis: current status and future trends (Q38685682) (← links)
- A modified procedure based on a vacuum-driven blotting system for the detection of erythropoietin and its analogs (Q38970172) (← links)
- Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions (Q39100829) (← links)
- The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design (Q39433211) (← links)
- A functional analysis of N-glycosylation-related genes on sialylation of recombinant erythropoietin in six commonly used mammalian cell lines. (Q39657956) (← links)
- Involvement of the health industry in the fight against doping in sport (Q39730687) (← links)
- Differences in capillary electrophoresis profiles of urinary and recombinant erythropoietin (Q40668618) (← links)
- Acute hyperhydration reduces athlete biological passport OFF-hr score. (Q41430233) (← links)
- Erythropoietin use and abuse (Q41822845) (← links)